Tom R. Jones

793 total citations
15 papers, 337 citations indexed

About

Tom R. Jones is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Tom R. Jones has authored 15 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Tom R. Jones's work include Synthesis and Reactions of Organic Compounds (3 papers), Receptor Mechanisms and Signaling (3 papers) and Phosphodiesterase function and regulation (3 papers). Tom R. Jones is often cited by papers focused on Synthesis and Reactions of Organic Compounds (3 papers), Receptor Mechanisms and Signaling (3 papers) and Phosphodiesterase function and regulation (3 papers). Tom R. Jones collaborates with scholars based in Canada, United States and Germany. Tom R. Jones's co-authors include L. Charette, María L. García, Gregory J. Kaczorowski, M. McAuliffe, Yves Girard, Christine Brideau, Yves Ducharme, Pierre Hamel, H. Piechuta and Nathalie Chauret and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

Tom R. Jones

14 papers receiving 311 citations

Peers

Tom R. Jones

PHYSI

PHARM

CCM

Motonori Aoki Japan

George L. Kramer United States

N. Wesley Norton United States

Herman J. Crowley United States

Franklin J. Rosenberg United States

Akira Tomiyama Japan

David L. Saussy United States

Hilmi Burak Kandilci Türkiye

Norihiro Takenaga Japan

Nelson C. F. Yim United States

Motonori Aoki Japan

Tom R. Jones

152 ×0.8

72 ×0.7

63 ×0.7

PHYSI

59 ×1.2

PHARM

23 ×0.6

CCM

Citations per year, relative to Tom R. Jones Tom R. Jones (= 1×) peers Motonori Aoki

Countries citing papers authored by Tom R. Jones

Since Specialization

Citations

This map shows the geographic impact of Tom R. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom R. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom R. Jones more than expected).

Fields of papers citing papers by Tom R. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom R. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom R. Jones. The network helps show where Tom R. Jones may publish in the future.

Co-authorship network of co-authors of Tom R. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Tom R. Jones. A scholar is included among the top collaborators of Tom R. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom R. Jones. Tom R. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Frenette, Richard, Marc Blouin, Christine Brideau, et al.. (2002). Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters. Bioorganic & Medicinal Chemistry Letters. 12(20). 3009–3013. 20 indexed citations

Guay, Daniel, Pierre Hamel, Marc Blouin, et al.. (2002). Discovery of L-791,943: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor. Bioorganic & Medicinal Chemistry Letters. 12(11). 1457–1461. 45 indexed citations

Frenette, Richard, John H. Hutchinson, Serge Léger, et al.. (1999). Substituted indoles as potent and orally active 5-lipoxygenase activating protein (FLAP) inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(16). 2391–2396. 11 indexed citations

Guay, Daniel, J. Y. GAUTHIER, C. DUFRESNE, et al.. (1998). A series of non-quinoline cysLT1 receptor antagonists: Sar study on pyridyl analogs of singulair®. Bioorganic & Medicinal Chemistry Letters. 8(5). 453–458. 7 indexed citations

Jones, Tom R., M. McAuliffe, C. S. McFarlane, et al.. (1998). Effects of a selective phosphodiesterase IV inhibitor (CDP-840) in a leukotriene-dependent non-human primate model of allergic asthma.. PubMed. 76(2). 210–7. 20 indexed citations

Lehmann, John, et al.. (1996). A Novel Microdialysis Probe Designed for Clinical Use: Potential Analytical and Therapeutic Applications. PubMed. 67. 66–69. 4 indexed citations

Delorme, Daniel, Yves Ducharme, Christine Brideau, et al.. (1996). Dioxabicyclooctanyl Naphthalenenitriles as Nonredox 5-Lipoxygenase Inhibitors: Structure−Activity Relationship Study Directed toward the Improvement of Metabolic Stability. Journal of Medicinal Chemistry. 39(20). 3951–3970. 51 indexed citations

Hutchinson, John H., S. Charleson, Jilly F. Evans, et al.. (1996). ChemInform Abstract: Thiopyranol(2,3,4‐c,d)indoles as Inhibitors of 5‐Lipoxygenase, 5‐ Lipoxygenase‐Activating Protein, and Leukotriene C4 Synthase.. ChemInform. 27(10). 4 indexed citations

Lau, Cheuk K., C. DUFRESNE, Yves Gareau, et al.. (1995). Evolution of a series of non-quinoline leukotriene D4 receptor antagonist; synthesis and sar of benzothiazoles and thiazoles substituted benzyl alcohols as potent LTD4 antagonists. Bioorganic & Medicinal Chemistry Letters. 5(15). 1615–1620. 27 indexed citations

10.

Hutchinson, John H., Denis Riendeau, Christine Brideau, et al.. (1994). Thiopyrano[2,3,4-cd]indoles as 5-Lipoxygenase Inhibitors: Synthesis, Biological Profile, and Resolution of 2-[2-[1-(4-Chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5-dihydro-1H-thiopyrano[2,3,4-cd]indol-2-yl]ethoxy]butanoic Acid. Journal of Medicinal Chemistry. 37(8). 1153–1164. 14 indexed citations

11.

Hutchinson, John H., Denis Riendeau, Christine Brideau, et al.. (1994). ChemInform Abstract: Substituted Thiopyrano(2,3,4‐c,d)indoles as Potent, Selective, and Orally Active Inhibitors of 5‐Lipoxygenase. Synthesis and Biological Evaluation of L‐691,816.. ChemInform. 25(10).

12.

Jones, Tom R. & L. Charette. (1990). Inhibition of relaxation of guinea-pig trachea by the K+ -channel antagonist, charybdotoxin (CHTX). European Journal of Pharmacology. 183(6). 2131–2132. 1 indexed citations

13.

Jones, Tom R., L. Charette, María L. García, & Gregory J. Kaczorowski. (1990). Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 255(2). 697–706. 115 indexed citations

14.

Moran, R G, Paul D. Colman, & Tom R. Jones. (1989). Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.. Molecular Pharmacology. 36(5). 736–743. 12 indexed citations

15.

Masson, P., et al.. (1982). Biological activity of leukotriene sulfones on respiratory tissues. International Journal of Immunopharmacology. 4(4). 351–351. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact